Bjoern M Hock
Founder and CEO, Lavaux Biotech consulting; CDO Tubulis GmbH
Before
- Founder and CEO at Lavaux Biotech Consulting SARL
- Chief Development Officer at Tubulis GmbH
- Interim CEO and Head European Offices at Swissthera SA (Aerium Therapeutics)
- VP Biologics Technologies and Development at Ferring Pharmaceuticals
- Director, Global head Protein Engineering and Antibody Technologies at Healthcare Business of Merck
- Director, Protein Engineering and Antibody Technologies at Healthcare Business of Merck
- Dirctor, Binders and Protein Engineering at Healthcare Business of Merck
- Senior Dirctor, Antibody Drug Conjugates and Targeted NBE Therapeutics at Merck KGaA, Darmstadt, Germany